Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change
28/10/26	€0.6400	0.00%
27/10/26	€0.6400	0.00%
26/10/26	€0.6400	0.00%
23/10/26	€0.6400	0.00%
22/10/26	€0.6400	0.00%

Real-time Euronext Paris

More quotes

Market Closed - Euronext Paris 20:55:00 28/10/2026 +04			5-day change	1st Jan Change
0.6400 ^EUR	0.00%		0.00%	-63.43%

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 142K 118K 107K 199K 13.54M 202K 1.41M 561K 7.08M 533K 522K 22.49M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 14.76M 12.24M 11.09M 20.71M 1.41B 20.96M 146M 58.29M 735M 55.38M 54.21M 2.33B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
12-01	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/07/25	Alert wrongly tagged to Safe SA withdrawn	RE
27/12/24	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/09/24	The market burns its idols
05/02/24	Safe: wins its appeal against Neo Medical
28/12/23	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/09/24	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
24/11/23	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

Safe S.A. Stock

Stocks

ALSAF

FR001400ZU25

Medical Equipment, Supplies & Distribution

Valuation: Safe S.A.

Chart: Safe S.A.

Latest news: Safe S.A.

Press Releases: Safe S.A.

News in other languages: Safe S.A.

Quotes and Performance

Price Extremes

Managers and Directors: Safe S.A.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

09-08	SAFE : point sur l'audience du 7 septembre 2026 devant le Tribunal des activités économiques de Lyon
08-25	SAFE Group : point sur la suspension de cotation et sur la certification des comptes annuels 2025
06-30	Safe Group améliore nettement ses résultats annuels
05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group

1 week	0.64	0.64
1 month	0.64	0.64
Current year	0.54	1.81
1 year	0.54	2.6
3 years	0.54	141,014.1
5 years	0.54	4,417,799,955.82
10 years	0.54	10,000,000,000

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	15/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	09/11/2017

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	26/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	26/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE S.A.	0.00%	0.00%	-73.33%	-100.00%	142K
ABBOTT LABORATORIES	-0.45%	+2.12%	-18.93%	+10.54%	178B
STRYKER CORPORATION	+0.86%	+2.15%	-19.13%	+16.07%	116B
MEDTRONIC PLC	+0.88%	+1.88%	+1.66%	+36.51%	115B
ESSILORLUXOTTICA	-2.26%	+2.24%	-44.03%	+5.76%	93.1B
CENCORA, INC.	-0.31%	-4.72%	-3.36%	+72.86%	62.09B
HOYA CORPORATION	-0.74%	-0.57%	+9.96%	+83.11%	55.87B
BECTON, DICKINSON AND COMPANY	+0.07%	+0.42%	+5.94%	-22.43%	53.12B
IDEXX LABORATORIES, INC.	+0.30%	+1.70%	-11.26%	+43.83%	44.22B
ALCON INC.	+0.10%	+3.08%	-3.06%	-8.71%	33.59B
Average	-0.15%	+2.05%	-15.56%	+13.75%	75.1B
Weighted average by Cap.	-0.17%	+2.37%	-12.56%	+24.09%

	2024	2025
Net sales	5.04M 5.62M 4.66M 4.22M 7.89M 535M 7.98M 55.72M 22.2M 280M 21.08M 20.64M 889M	5.36M 5.98M 4.96M 4.49M 8.39M 569M 8.49M 59.29M 23.62M 298M 22.44M 21.96M 946M
Net income	-1.93B -2.15B -1.78B -1.62B -3.02B -205B -3.05B -21.33B -8.49B -107B -8.07B -7.9B -340B	-4.67M -5.21M -4.32M -3.91M -7.31M -496M -7.4M -51.67M -20.58M -260M -19.55M -19.14M -824M
Net Debt	11.47M 12.79M 10.61M 9.6M 17.94M 1.22B 18.16M 127M 50.51M 637M 47.98M 46.97M 2.02B	13.11M 14.61M 12.12M 10.98M 20.51M 1.39B 20.76M 145M 57.73M 728M 54.84M 53.68M 2.31B